M., & Srivastava, D
However, the lack of drug-like characteristics, such as poor target specificity and selectivity, high toxicity, several off-targets, severe side effects, poor metabolic stability, poor membrane permeability and rapid proteolysis, make this molecule fairly unsuitable candidates for therapeutic applications
Patients should not discontinue metformin due to concerns about neuropathy without consulting their healthcare provider, as the benefits of glycemic control typically outweigh the manageable risk of B12 deficiency
(2015) conducted a meta-analysis of 6 randomized controlled trials involving Cerebrolysin in Alzheimer's disease, finding statistically significant improvements in global clinical outcomes and cognitive measures at 24 weeks (PMID: 25832905) Cochrane Systematic Review: Cui et al
Delta Sleep-Inducing Peptide , or DSIP for short, isnt just a regular compound